Yun Zhong
Stock Analyst at BTIG
(0.77)
# 4,476
Out of 4,479 analysts
14
Total ratings
41.18%
Success rate
-8.09%
Average return
Main Sectors:
Top Industries:
9 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| AVXL Anavex Life Sciences | Maintains: Buy | $35 → $28 | $4.13 | +577.97% | 2 | Feb 9, 2023 | |
| TSHA Taysha Gene Therapies | Downgrades: Neutral | n/a | $2.16 | - | 2 | Feb 2, 2023 | |
| FOLD Amicus Therapeutics | Maintains: Buy | $14 → $16 | $9.85 | +62.44% | 1 | Jan 18, 2023 | |
| SRPT Sarepta Therapeutics | Maintains: Buy | $125 → $160 | $154.20 | +3.76% | 4 | Dec 22, 2022 | |
| RCKT Rocket Pharmaceuticals | Initiates: Buy | $35 | $19.78 | +76.95% | 1 | Nov 1, 2022 | |
| BLUE bluebird bio | Downgrades: Hold | n/a | $0.92 | - | 1 | Jul 1, 2021 | |
| QURE uniQure | Initiates: Buy | n/a | $4.01 | - | 1 | Jun 15, 2021 | |
| PASG Passage Bio | Initiates: Buy | n/a | $1.00 | - | 1 | Jun 15, 2021 | |
| MREO Mereo BioPharma Group | Initiates: Buy | n/a | $3.45 | - | 1 | May 5, 2021 |
Anavex Life Sciences
Feb 9, 2023
Maintains: Buy
Price Target: $35 → $28
Current: $4.13
Upside: +577.97%
Taysha Gene Therapies
Feb 2, 2023
Downgrades: Neutral
Price Target: n/a
Current: $2.16
Upside: -
Amicus Therapeutics
Jan 18, 2023
Maintains: Buy
Price Target: $14 → $16
Current: $9.85
Upside: +62.44%
Sarepta Therapeutics
Dec 22, 2022
Maintains: Buy
Price Target: $125 → $160
Current: $154.20
Upside: +3.76%
Rocket Pharmaceuticals
Nov 1, 2022
Initiates: Buy
Price Target: $35
Current: $19.78
Upside: +76.95%
bluebird bio
Jul 1, 2021
Downgrades: Hold
Price Target: n/a
Current: $0.92
Upside: -
uniQure
Jun 15, 2021
Initiates: Buy
Price Target: n/a
Current: $4.01
Upside: -
Passage Bio
Jun 15, 2021
Initiates: Buy
Price Target: n/a
Current: $1.00
Upside: -
Mereo BioPharma Group
May 5, 2021
Initiates: Buy
Price Target: n/a
Current: $3.45
Upside: -